Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Apr 13.
Published in final edited form as: Heart Rhythm. 2014 Jun 19;11(11):2107–2115. doi: 10.1016/j.hrthm.2014.06.023

How do sex hormones modify arrhythmogenesis in long-QT syndrome? – Sex hormone effects on arrhythmogenic substrate and triggered activity

Katja E Odening 1, Gideon Koren 2
PMCID: PMC4394187  NIHMSID: NIHMS678538  PMID: 24954242

Abstract

Gender differences in cardiac repolarization and the arrhythmogenic risk of patients with inherited and acquired long-QT syndromes are well appreciated clinically. Enhancing our knowledge of the mechanisms underlying these differences is critical to improve our therapeutic strategies for preventing sudden cardiac death in such patients.

This review summarizes the effects of sex hormones on the expression and function of ion channels that control cardiac cell excitation and repolarization as well as key proteins that regulate Ca2+ dynamics at the cellular level. Moreover, it examines the role of sex hormones in modifying the dynamic spatiotemporal (regional and transmural) heterogeneities in action potential duration (e.g., the arrhythmogenic substrate) and the susceptibility to (sympathetic) triggered activity at the tissue, organ, and whole-animal levels. Finally, it explores the implications of these effects on the management of LQTS patients.

Keywords: long-QT syndrome, mechanisms of arrhythmogenesis, dispersion of cardiac repolarization, early afterdepolarizations, gender differences, sex hormones, ion channels, Ca2+ cycling proteins, adrenoceptors, animal models

Introduction

Women with inherited or acquired long-QT syndrome (LQTS) have longer QT intervals and are more prone to develop additional drug-induced QT prolongations, polymorphic ventricular tachycardia (pVT), and sudden cardiac death (SCD) than men1, 2. Several observations suggest an important role for sex hormones in conferring these gender differences; different phases of the menstrual cycle, pregnancy, and the postpartum period are all associated with changes in QT duration and the incidence of pVTs in LQTS patients3, 4.

This review explores the mechanisms underlying these gender differences and sex hormone effects at the cellular, tissue, organ, and whole-animal levels in order to identify potential novel therapeutic approaches to prevent arrhythmias and SCD in LQTS patients. Specifically, it recapitulates cellular sex hormone effects on the transcription, protein expression, post-translational modification, and function of cardiac ion channels and Ca2+ cycling proteins. Moreover, this review explores sex hormone effects on the arrhythmogenic substrate and triggered activity and their modulation by sympathetic stimulation.

Cellular level: Mechanisms underlying gender differences and sex hormone effects on ion channels, calcium cycling proteins, and triggered activity

Major determinants of the duration of cardiac repolarization include repolarizing voltage-gated rapid delayed rectifier current IKr (alpha-subunit HERG), slow delayed rectifier current IKs (alpha- and beta-subunits KvLQT1 and KCNE1), and inward rectifier current IK1 (Kir2.1), as well as depolarizing L-type Ca2+ current ICa,L (alpha-subunit Cav1.2) and the activity of Na+/K+ ATPase. IKr and IK1 current densities are lower in ventricular cardiomyocytes of female rabbits than in males5. The lower IKr current density in females that reduces the “repolarization reserve” is thought to be of major importance for females' higher sensitivity to IKr-blocking drugs and their prolonged action potential duration (APD)5. Increased activity of cardiac Na+/K+ ATPase in female rats6 that shortens the duration of cardiac repolarization, particularly at fast heart rates, may contribute to the steepening of the QT/RR slope in females. Recently, similar findings of gender differences in cardiac repolarizing ion currents have also been detected in human cardiac tissue derived from non-diseased transplant donors. Using a high-throughput quantitative approach, Gaborit et al.7 demonstrated lower transcript and protein expression of several repolarizing K+-channel subunits – such as HERG, KCNE1, and Kir2.3 – in female cardiac tissue derived from RV and LV base regions, compared with analogous male tissue.

Sex hormone effects on the (regionally heterogeneous) expression and function of these ion channels may contribute to gender differences in the arrhythmogenic substrate. Sex hormones may influence the expression and function of cardiac ion channels via sex hormone receptor-mediated genomic modulation of their expression or of their posttranslational phosphorylation state or by an acute, non-genomic regulation of ion current densities involving nitric oxide8 (Table 1).

Table 1.

Gender and sex hormone effects on cardiac repolarization and LQT-related arrhythmogenesis on cellular and whole-heart levels

Sex Intervention Ion currents Magnitude
of changes
Cardiac
region
Level of
changes
Species Ca2−cycling
proteins
Magnitude
of changes
Cardiac
region
Level of
changes
Species APD
in rabbits
EADs in
LQT rabbits
Male -------- ↑ IKr
↑ IK1
compared to females [5]
+ 30%
+ 15%
LV
LV
current
current
rabbit
rabbit
↓ NCX
compared to females [32]
−2.5-fold
−55%
LV base
LV base
activity protein rabbit
rabbit
↓ APD
compared to females [5]
ORCH ↓ IKr
↓ IK1 [15]
−40%
−50%
LV
LV
current
current
rabbit
rabbit
↓ RyR2
↓ SERCA
↓ PLN-phos
↓ NCX [28]
−25%
−30%
−25%
−15%
LV
LV
LV
LV
activity, ISO
activity, ISO
Ser16-phos
activity, PE
rat
rat
rat
rat
↑ APD
compared to males [15, 44]
ORCH+DHT ↑ IKr
↑ IKs
↑ IK1
↓ ICa,L

↑ ICa,L [8, 10, 15, 44]
+ 40%
+ 45%
+ 50–60%
−40%
−50%
+ 2.5-fold
+ 2-fold
LV
LV
LV
LV
LV
LV
LV
current
current, eNOS
current
current, acute
current, acute
current, chron
protein, chron
rabbit
guinea pig
rabbit
guinea pig
rat
rat
rat
↑ RyR2
↑ SERCA
↑ NCX
[28]
+ 25%
+ 30%
+ 15%
LV
LV
LV
activity, ISO
activity, ISO
activity, PE
rat
rat
rat
↓ APD
compared to ORCH [15, 44]
Female -------- ↓ IKr
↓ IK1
↑ ICa.L (grad) compared to males/OVX [5, 44, 45]
−30%
−15%
+ 30%
+ 70%
+ 3-fold
LV
LV
LV base
LV base
LV base
current
current
current
protein
mRNA
rabbit
rabbit
rabbit
rabbit
rabbit
↑ NCX
compared to males [32]
+ 2.5-fold
+ 55%
LV base
LV base
activity protein rabbit
rabbit
↑ APD
compared to males [5]
↑ EADs
compared to DHT and PROG [25]
OVX ↑ RyR2
↓ SERCA

↓ PLN-phos
↓ NCX [27, 30, 33]
+ 2-fold
−15%
−25%/−3-fold
−30%
−40%
LV
LV
LV
LV
LV apex
activity
activity
protein/mRNA
Thr17-phos
protein
rat
rat
rat
rat
rat
↓ APD
compared to females [44]
↑ EADs
compared to DHT and
PROG [25]
OVX+EST ↓ IKr
↑ KCNE2
↑ IKs
↓ KCNE1
↑ ICa,L [8, 9, 13, 14, 16, 25, 44]
−25–35%
+ 4.5-fold
+ 35%
no expr
+ 30%
+ 40–100%
+ 20%
+ 30 %
LV
LV
LV
LV
LV apex
LV base
LV base
LV base
current
mRNA
current
mRNA
current, chron
current
protein
mRNA
guinea pig
rat
guinea pig
rabbit
rabbit
rabbit
rabbit
rabbit
↑ RyR2 leak
↑ PLN
↓ PLN-phos
↑ PLN-phos
↑ NCX
[27, 29, 30, 31, 32, 34]
+ 50%
+ 30%
−10-fold
+ 30%
+ 40%
+ 20–25%
+ 30%/+30%
+ 60%/+20%
LV
LV apex
LV
LV
LV apex
-
-
LV base
leakiness
mRNA
Ser16-phos
Thr17-phos
protein
activity, chron
mRNA/protein
activity/protein
rat
rat
rat
rat
rat
rat H9C2
rat H9C2
rabbit
↑ APD
compared to OVX [16, 44]
↑ EADs
compared to DHT and PROG [25]
OVX+DHT ↑ IKs
[25]
+ 50% LV apex current, chron rabbit ↑ EADs
compared to females and EST [25]
OVX+PROG ↑ IKs
↓ ICa,L
[8, 25]
+ 20–35%
−30%, cAMP
−25%
LV
LV
LV apex
current, eNOS
current, eNOS
current, chron
guinea pig
guinea pig
rabbit
↑ SERCA

↑ PLN-phos
[25, 27]
+ 50%
+ 15%
+ 30%
LV apex
LV
LV
protein
activity
Thr17-phos
rabbit
rat
rat
↓ EADs
compared to females and EST [25]

APD, action potential duration; EADs, early afterdepolarizations; ORCH, orchiectomy; OVX, ovariectomy; DHT, dihydrotestosterone; EST, estradiol; PROG, progesterone; IKr, rapidly delayed rectifier K+ current; IKs, slow delayed rectifier K+ current; IK1, inward rectifier K+ current; ICa,L, L-type Ca2+ current; KCNE1, beta-subunit to KvLQT1 to form IKs; KCNE2, beta-subunit to HERG to form IKs,; NCX, sodium calcium exchanger; SERCA, sarcoplasmatic reticulum ATPase; RyR, ryanodine receptor; LV, left ventricle (region not further specified); grad, base-to-apex gradient. ↑ indicates an increase; ↓ indicates a reduction; ↑ APD indicates an APD prolongation; ↓ APD indicates an APD shortening. Chron, chronic hormone effects; Phos, phosphorylation; eNOS, acute eNOS-mediated mechanism; cAMP, under cAMP stimulated condition; PE, under phenylephrine stimulation; ISO, under isoproterenol stimulation; rat H9C2, rat H9C2 cell line

However, since the concentrations of sex hormones used and durations of hormone treatment vary, it is challenging to integrate data from all available studies into one concise picture. Ideally, sex hormone effects should be studied using physiological hormone dosages; e.g., 1) Estradiol concentrations could range from 15 to 350 pg/ml corresponding to the physiological levels in post-pubertal premenopausal women during the different phases of normal menstrual cycle and could reach up to 7,000 pg/ml as during pregnancy, 2) Progesterone concentrations could range from 0.3 to 1.2 ng/ml corresponding to the physiological levels during follicular phase, from 1.7 to 27 ng/ml as during luteal phase and could reach up to 340 ng/ml as during pregnancy, 3) Dihydrotestosterone concentrations could range from 120 to 1000 pg/ml and testosterone concentrations could range from 3000 to 12.000 pg/ml corresponding to the physiological levels in healthy post-pubertal adult men (ACP reference ranges, Mayo Clinic reference ranges). However, in the different studies available, estradiol concentrations ranging from 30 pg/ml up to 2,000 ng/ml, progesterone concentrations from 0.3 up to 3,000 ng/ml, dihydrotestosterone concentrations from 200 up to 900 pg/ml, and testosterone concentrations from 300 pg/ml up to 300 ng/ml were utilized. This is particularly important, since it is known 1) that sex hormone concentrations above naturally occurring physiological levels may exert differential, partially opposing effects on ion currents and channel expression (as demonstrated for estradiol’s effects on IKr9) and 2) that acute and chronic hormone effects may counteract each other (as demonstrated for testosterone’s effects on ICa,L10). Since rabbits have repolarizing ion current characteristics similar to humans and mimic human gender differences in LQT-related arrhythmias and cardiac repolarization5, 11, 12, this review focuses mainly on rabbit studies investigating sex hormone effects on cardiac repolarizing currents on both the whole-heart and animal levels.

IKr can be directly inhibited by estradiol9, 13 and can also be reduced indirectly by estradiol-induced increased transcription of the beta-subunit KCNE214. Moreover, estradiol and IKr-blocking drugs exert a synergistic effect on IKr13. In contrast, testosterone acutely increases IKr and IK115, while other sex hormones have no direct effect on the inward rectifier current. Similarly, IKs can be acutely increased by testosterone or progesterone via a non-genomic pathway involving NO8, while estradiol indirectly reduces IKs by downregulating mRNA levels of the beta-subunit KCNE116. Thus far, sex hormone effects on the expression and activity of Na+/K+ ATPase have only been investigated in arteries (not in cardiomyocytes), demonstrating an estradiol-induced increased function and mRNA expression of its isoform 217. Whether similar sex hormone effects may be found in cardiac muscle–specific isoforms remains to be investigated. All these hormone-induced alterations of ion current densities or the expression of its subunits result in a net estradiol-induced prolongation of APD and a net testosterone- and progesterone-induced shortening of APD (Table 1).

Reactivation of ICa,L currents plays an important role in the formation and propagation of early afterdepolarizations (EADs)18. Additionally, Ca2+ cycling proteins such as the ryanodine receptor (RyR2), the sodium calcium exchanger (NCX), the sarcoplasmic reticulum ATPase 2a pump (SERCA), phospholamban (PLN), and the Ca2+-calmodulin-dependent protein kinase-II (CaMKII) are known to contribute to or prevent the formation of EADs by altering cytoplasmic and sarcoplasmic reticulum (SR) Ca2+ concentrations, spontaneous Ca2+ release, and Ca2+ transient characteristics. An increased intracellular Ca2+ concentration or spontaneous SR Ca2+ release may thereby activate NCX in its forward mode, thus prolonging action potential duration to allow the activation of the window ICa,L current or the re-activation of INa in late phase 3 repolarization thereby eliciting an EAD.

Sex hormone effects on the expression and function of Ca2+ cycling proteins may thus contribute to gender differences in the susceptibility to triggered activity (Table 1). Since PKA- or CamKII-mediated phosphorylation of these Ca2+ cycling proteins alters their function – e.g., phosphorylation of L-type Ca2+ channel increases ICa,L current, phosphorylation of PLN diminishes its inhibitory effects on SERCA, and phosphorylation of RyR2 increases its open probability – sex hormones may exert their effects on the activity of Ca2+ cycling proteins partly by altering their phosphorylation state. Moreover, since previous studies have demonstrated gender differences in intracellular Ca2+ transient characteristics with longer Ca2+ transient durations, as well as a slower rate of rise and a greater spatial Ca2+ transient variability in female rats’ cardiomyocytes19, 20, sex hormone effects on Ca2+ cycling proteins may also account for differences in Ca2+ transients. Indeed, estradiol increases Ca2+ transient amplitudes in rat cardiomyocytes21, while testosterone shortens Ca2+ transient duration22.

Since most studies investigating sex hormone effects on Ca2+ cycling properties and Ca2+ transients were performed on rodents, we have integrated this information into the review, despite the fact that rodents have different repolarization characteristics than human subjects and lack some of the gender differences in cardiac repolarization and arrhythmia vulnerability observed in human subjects11, 23. Moreover, ICa,L recovery from inactivation, which is important for EAD formation, requires an action potential long enough to enable the reactivation of the L-type Ca2+ “window current” within its voltage range24. The AP in rodents, however, is too short for the reactivation of the ICa,L window current. Thus, data on sex hormone effects on Ca2+ cycling properties from rodents may not necessarily reflect (all) sex hormone effects on Ca2+ dynamics and triggered activity in human subjects. Nevertheless, we added this information since these data may give some idea about the effects of sex hormones on Ca2+ dynamics that may contribute to their pro- or anti-arrhythmic effects.

Estradiol increases ICa,L current density in rabbits, likely enhancing the propensity to develop EADs25. Acute and chronic progesterone and acute testosterone exposure, in contrast, decrease ICa,L current densities8, 10, 25. The acute direct ICa,L-blocking effects of testosterone over the physiological range of concentrations will be dominant in the short-term time scale. Chronic exposure to testosterone, however, may eventually result in a contrasting increase in channel expression and ICa,L current densities (at higher concentrations)10, 26, though repeated acute exposure to testosterone could mask these chronic effects.

SERCA expression and activity in rats and rabbits are reduced by ovariectomy27 and can be restored by progesterone and testosterone25, 27, 28. This progesterone-induced increased SERCA expression and activity25 may contribute to progesterone’s anti-arrhythmic effect by increasing the Ca2+ reuptake into the SR, thus shortening Ca2+ transient duration. Thr17-phosphorylation of PLN, which inhibits phospholamban’s SERCA-inhibitory effect, is reduced by ovariectomy in rats, resulting in a net reduction of SERCA activity27. This effect can be partly reversed by estradiol or progesterone replacement27. Ser16-phosphorylation of PLN, in contrast, is reduced by estradiol via an ERβ-mediated mechanism involving PIK3, thus partly counteracting the above-described effects29. NCX expression can also be reduced by ovariectomy30, while estradiol increases its transcription, protein expression, and activity in rabbits, rats, and the embryonic rat cardiomyoblast cell line H9C230, 31, 32. This estradiol-effect may contribute to the increased EAD formation observed in female rabbits. Testosterone also increases NCX transcription and activity in rats33. However, increased function of NCX is accompanied and counteracted by testosterone-induced increased function of SERCA28, thus leading to a faster removal of Ca2+ from the cytosol and shortened Ca2+ transient duration (Table 1). In ovariectomized rats, PKA-mediated increased RyR2 activity leads to increased Ca2+ release from the SR into the cytosol33. Similarly, testosterone increases RyR2 activity28. Estradiol, however, increases the leakiness of RyR2 via an ERβ-mediated mechanism, thereby increasing the risk of pro-arrhythmic afterdepolarizations34. The net overall effects of sex hormones on Ca2+ transients and triggered activity, however, are hard to predict or model due to the lack of comprehensive studies that thoroughly investigated these different and partially opposing effects. There is ample evidence, however, that female gender and estradiol may at least increase ICa,L currents25, 32, NCX activity32 and RyR2 leakiness34 thus increasing the propensity for triggered activity, while testosterone and progesterone may increase SERCA activity either directly or by altering phospholamban phosphorylation25, 27, 28 and acutely decrease ICa,L8, 10, 25 thus reducing the likelihood for triggered activity.

There are known feedback mechanisms between Ca2+ transients and action potential duration, including an inactivation of ICa,L currents induced by SR Ca2+ release that results in an APD shortening as well as an increase in NCX activity induced by SR Ca2+ release with the opposite (prolonging) effect on APD35. Consequently, any sex hormone effects on the activity of Ca2+ cycling proteins and Ca2+ transients may also indirectly affect APD and may have either synergistic or opposing effects on APD relative to the hormone’s direct effects on ion currents. The testosterone-induced increased Ca2+ release via RyR228 may lead to a faster inactivation of ICa,L, creating a synergistic effect on APD with the testosterone-induced reduction of ICa,L10. Similarly, testosterone-induced increased Ca2+ release from the SR may enhance NCX activity, creating a synergistic effect with testosterone’s direct effects on the transcription and activity of NCX28, thereby partly counteracting the aforementioned APD-shortening effects. However, the effects of estradiol on the leakiness of RyR234 and the increased Ca2+ transient amplitudes in rat cardiomyocytes23 may partly counteract the direct effects of estradiol on ICa,L and thus on APD. Future studies of the effect of sex hormones on ion currents and Ca2+ dynamics should include modelling of these feedback mechanisms to reconcile and integrate sex hormone effects on AP duration and triggered activity.

Sympathetic α1-adrenergic receptor-activation facilitates EAD formation and prolongs APD by reducing IKr and IK1. Any sex hormone effects on the response to sympathetic α1-adrenergic stimulation, such as an estradiol-induced increase in α1-adrenoceptor responsiveness36, may therefore affect APD and the susceptibility to EAD formation. β-adrenergic stimulation enhances IKs via G-protein-mediated phosphorylation of KvLQT1 and thereby shortens APD. Additionally, β-adrenergic stimulation enhances ICa,L – which, because it occurs faster than that the increase of IKs, leads to an initial APD prolongation and increased EAD formation in a situation of short sudden sympathetic surge37. In the presence of the β-sympathomimetic drug isoproterenol, APD shortens upon faster pacing in male dogs, while the opposite is seen in females38, strongly suggesting gender differences in the autonomic modulation of IKs and ICa,L. In rats, ovariectomy induces an upregulation39 of β1-adrenoceptor expression, while estrogen induces its downregulation30, 40. β2-adrenoceptor expression, in contrast, is upregulated by estradiol41 and is higher in female than in male rat cardiomyocytes41, indicating that sex hormones may indeed modulate cardiac responses to sympathetic stimulation by altering cardiac expression of β1 and β2-adrenergic receptors.

Tissue and organ level: Mechanisms underlying gender differences and sex hormone effects on the arrhythmogenic substrate and triggered activity

Regional and transmural spatial heterogeneities in APD as well as dynamic temporal APD changes, forming the so-called “arrhythmogenic substrate,” are of major importance for re-entry formation in arrhythmias related to long QT42. Spatial and transmural heterogeneities in IKr, IKs, and ICa,L current densities underlie these pronounced APD heterogeneities in LQTS43, 44. However, few studies have investigated gender differences and sex hormone effects on spatial APD heterogeneities and the underlying spatially heterogeneously expressed ion channels at the tissue and organ levels. In female rabbits but not in males, there is a transmural and base-to-apex gradient of ICa,L with a higher conductance of ICa,L in epi- than endocardial and basal than apical cells44, 45. Ovariectomy eliminates the transmural gradient, which reappears upon treatment with estradiol44. In contrast, there is no transmural gradient in orchiectomized rabbits even after exposure to estradiol44, suggesting a potential gender difference in the mechanism of action of sex hormones. Moreover, estradiol increases the base-to-apex gradient of ICa,L in rabbits46. However, to date, there are no experimental data available analyzing gender differences or sex hormone effects on transmural or base-to-apex distribution of IKs or IKr that might contribute to the observed gender differences in dispersion of repolarization.

Moreover, since sympathetic stimulation decreases the transmural dispersion of refractoriness47, gender differences and sex hormone effects on (spatial inhomogeneities of) β1 and β2-adrenoceptor expression might produce marked discrepancies in APD and thereby facilitate ventricular arrhythmias. However, to date, no studies have investigated sex hormone effects on spatial differences in cardiac adrenoceptor expression and activity.

Animal models: Gender differences and sex hormone effects on the arrhythmogenic substrate in animal models of drug-induced and inherited LQTS

Similar to human subjects, rabbits exhibit pronounced gender differences in duration and dispersion of repolarization and are thus often used to explore such differences and their underlying mechanisms. Compared with males, female rabbits have longer QT intervals5, a steeper QT/RR slope48, and a more pronounced IKr-blocker induced QT prolongation and transmural APD dispersion44.

Experiments involving castration and subsequent exposure to sex hormones can reveal the impact of different hormones on cardiac repolarization: Ovariectomized female and castrated male rabbits exhibit similar ventricular APD9044. Moreover, orchiectomized rabbits have longer APD than intact males, while ovariectomized females have decreased drug-induced prolongation of APD compared to intact females44, thus reversing the normal gender differences in drug-induced APD or QT prolongation. The normal female phenotype can be mimicked by treating ovariectomized or orchiectomized rabbits with estradiol16, 44. Exposure to testosterone, in contrast, shortens QT and reduces the extent of drug-induced QT prolongation44 (Tables 1 and 2).

Table 2.

Gender and sex hormone effects on cardiac repolarization and LQT-arrhythmogenesis in rabbit models in vivo

Sex Intervention Drug-induced
QT-prolongation
Drug-induced
EADs / pVT
QT/RR slope steepness
in LQT rabbits
pVT / SCD
in LQT rabbits
Male -------- ↓ QT-prolongation
less pronounced than in females [5, 44]
↓ EADs
fewer than in females [5]
↓ QT/RR
less steep than in females [48]
ORCH ↑ QT-prolongation
more pronounced than in males [15, 44]
↑ EADs
more than in males [15, 44]
ORCH+DHT ↓ QT-prolongation
less pronounced than in ORCH [15, 44]
↓ EADs
reduced compared to ORCH [15, 44]
Female -------- ↑ QT-prolongation
more pronounced than in males [5, 44]
↑ EADs
more than in males [5]
↑ QT/RR
steeper than in males [48]
OVX ↓ QT-prolongation
less pronounced than in females [16, 44]
↓ EADs
reduced compared to females [16, 44]
↓ QT/RR
less steep than in females [25]
OVX+EST ↑ QT-prolongation
more pronounced than in OVX [16, 44]
↑ EADs
more than in OVX [16, 44]
↑ QT/RR
steeper than in OVX [25]
↑ pVT, ↑ SCD
increased incidence of arrhythmias [25]
OVX+DHT ↓ QT/RR
less steep than in females and EST [25]
no pVT, no SCD
decreased incidence of arrhythmias [25]
OVX+PROG no pVT, no SCD
decreased incidence of arrhythmias [25]

EAD, early afterdepolarization; pVT, polymorphic ventricular tachycardia; SCD, sudden cardiac death; ORCH, orchiectomy; OVX, ovariectomy; DHT, dihydrotestosterone; EST, estradiol; PROG, progesterone; QT/RR, QT-interval to RR-interval ratio; ↑ indicates an increase; ↓ indicates a reduction.

In a transgenic LQT2 rabbit model over-expressing a loss-of-function pore mutation of the human HERG channel (HERG-G628S)49, estradiol steepens the QT/RR slope by prolonging QT particularly at slow heart rates, while testosterone decreases QT/RR steepness25, thereby mimicking the gender differences observed in human LQT patients (Table 2). Moreover, sex hormones differentially affect APD in different regions of the heart in transgenic LQT2 rabbits, and thus modify spatial APD dispersion. Estradiol induces a particularly pronounced APD prolongation in the LV and RV apex, increasing VF inducibility in estradiol-treated hearts25. In contrast, in prepubertal rabbits treated with the IKr-blocker E4031, male rabbits show a greater base-to-apex dispersion of repolarization and thus a higher incidence of EAD formation than do female rabbits50, suggesting that other sex-related factors besides sex hormones might influence the extent of dispersion of repolarization during (prepubertal) development.

Animal models: Gender differences and sex hormone effects on triggered activity in animal models of drug-induced and inherited LQTS

Like women, female rabbits have a higher incidence of drug-induced pVTs than males12. Castration reverses these gender differences: Orchiectomy increases the incidence of IKr-blocker-induced EADs, while ovariectomy has the opposite effect44. The normal female phenotype can be mimicked by estradiol treatment16, while combined treatment with estradiol and progesterone reduces the risk of drug-induced arrhythmias51. Similarly, testosterone reduces the risk of drug-induced EADs44 (Table 2).

In transgenic LQT2 rabbits, which develop spontaneous pVT and SCD49, estradiol exerts a pro-arrhythmic effect in vivo, while progesterone exerts an anti-arrhythmic, protective effect and completely abolishes pVTs and SCD25 (Table 2). On the organ level, a reduced rate of EAD formation in response to sympathetic stimulation has been identified as the mechanism underlying the protective effect of progesterone25.

Clinical observations: Gender differences in cardiac repolarization and arrhythmogenesis in patients with inherited or acquired LQTS

Patients with inherited LQTS demonstrate pronounced gender differences in cardiac repolarization and in arrhythmogenic risk: Adult women with LQT types 1 and 2 have longer QT intervals, a more pronounced transmural QT-dispersion, and a higher risk of pVTs and SCD than men2, 52. Moreover, female gender is a main independent risk factor for increased risk of life-threatening cardiac events during adulthood independent of the genotype or of the location of the mutation within the gene2, 53. Interestingly, in female patients with LQT2, the arrhythmogenic risk remains elevated after the onset of menopause54, suggesting that other gender-related factors besides sex hormones may contribute to gender differences in arrhythmogenesis. Before puberty, however, the incidence of arrhythmia (particularly in LQT1) is higher in boys than in girls, and the age at first cardiac event is younger in male than female LQT patients55.

Similarly, drug-induced, acquired LQTS is also strongly influenced by gender. A variety of different drugs that block IKr currents (including antiarrhythmics, gastrokinetics, antipsychotics, antidepressants, antihistamines, and antibiotics) can cause this serious side effect (see complete list on www.QTDrugs.org). This risk and the extent of drug-induced QT prolongation and pVTs are significantly higher in women than in men, with two-thirds of reported drug-induced pVTs occurring in women1, 56.

Clinical observations: Impact of sex hormones on the arrhythmogenic substrate and triggered activity in human subjects with inherited or acquired long-QT syndrome

Several observations suggest an important role for sex hormones in conferring these gender differences. The different phases of menstrual cycle, pregnancy, and the postpartum period are all associated with changes in QT duration and the incidence of pVT in patients with inherited and acquired LQTS. In acquired LQTS, drug-induced QT prolongation is more pronounced and the risk for pVTs is higher during menses and the follicular phase (with high estradiol serum levels) than during the luteal phase (with relatively higher progesterone levels)3. During pregnancy (with high progesterone levels), LQT2 patients have a reduced arrhythmogenic risk, while the risk markedly increases during the nine months postpartum4. These observations strongly suggest a pro-arrhythmic role for estradiol and an anti-arrhythmic effect of progesterone in humans. Additionally, other postpartum-related hormones such as oxytocin and prolactin may contribute to the heightened postpartal arrhythmogenic risk, as indicated in a recent study of transgenic LQT2 rabbits57.

Conclusions

Observations in human subjects and animal models indicate that the sex hormones estradiol, progesterone, and testosterone are responsible for most of the gender differences observed in the arrhythmogenic substrate (cardiac repolarization), the susceptibility to (sympathetic) triggered activity, and the resulting gender differences in arrhythmia incidence in LQTS. Estradiol prolongs QT duration, increases the risk for additional drug-induced QT prolongation independently of gender, and exerts a pro-arrhythmic effect in vivo and ex vivo, whereas testosterone and progesterone shorten QT duration and exert an anti-arrhythmic effect with a reduced susceptibility to sympathetic stimuli. Some of the underlying mechanisms involved are: 1) an estradiol-induced decrease in IKr current densities as well as increases in ICa,L, NCX expression and activity, RyR2 leakiness, Ca2+ transient amplitude, and α1- and β2-adrenoceptor responsiveness; 2) a testosterone-induced increase in IKr, IKs, and IK1 current densities, increased SERCA activity, and shortened Ca2+ transient duration; and 3) a progesterone-induced increase in IKs, increased SERCA expression and activity, and decreased ICa,L current densities with reduced Ca2+ oscillations upon sympathetic stimulation.

However, it is difficult to fully appreciate the complexity of sex hormone effects, not only on different single components of cardiac repolarization and excitability but also on the feedback interaction between Ca2+ transients and APD. This is because most studies have investigated hormone effects on only a very limited number of ion channels or Ca2+ cycling proteins. Moreover, comprehensive interpretation of data from studies of sex hormone effects on ion channels or Ca2+ cycling proteins is limited by the use of different sex hormone concentrations as well as different subject species. For example, mice and rats have different repolarization characteristics than human subjects and lack some of the gender differences in cardiac repolarization and arrhythmia vulnerability observed in human subjects11, 23. Rabbits have repolarizing ion currents similar to those of humans and mimic their gender differences in cardiac repolarization and arrhythmogenesis5, 11, 12. Ideally the effects of chronic sex hormone treatment should be studied using physiological hormone dosages, simultaneously targeting the activity of multiple ion currents, pumps, and Ca2+ dynamics in species with greater similarity to the human heart. Importantly, these studies should address such effects at the cellular, tissue, and organ levels.

Moreover, not all gender differences in cardiac repolarization and arrhythmogenesis can be completely recapitulated and explained by hormonal influences, as gender differences are also found in castrated and in prepubertal rabbits. Here, further investigations are warranted, focusing on possible genetic factors – or epigenetic modifications – responsible for these gender differences.

Clinical implications

As women with inherited LQTS are at higher risk for pVT, syncopes, and SCD than men and are particularly prone to develop lethal VTs during the postpartum phase2, 4, particularly close clinical monitoring of female LQTS patients is mandatory – especially in phases associated with changing hormone levels. Similarly, as women generally have a higher risk for drug-induced pVTs than men1, physicians should be particularly cautious when treating women with drugs with potential QT-prolonging properties.

Understanding the exact mechanisms that underlie sex hormone effects on cardiac repolarization and arrhythmogenesis in inherited and drug-induced LQTS will help to better discern the individual risk of LQTS patients and of healthy subjects treated with QT-prolonging drugs. Moreover, this understanding could help to develop future specific hormone-based anti-arrhythmic therapies. A recent community-based study determined that higher estradiol levels were associated with a higher risk for SCD in both sexes also in patients with ischemic heart disease. Those findings suggest an even broader potential impact of a deeper understanding of the exact mechanisms underlying sex hormone effects on arrhythmogenesis for risk stratification and treatment for a greater variety of arrhythmogenic diseases58.

Acknowledgements

The authors thank Dr. Dorit Koren for her valuable comments regarding sex hormone levels in human subjects.

Funding Sources

K.E. Odening was supported by grants from the German Cardiac Society (St. Jude Medical Stipendium), the German Research Foundation (DFG Forschungsstipendium OD 86/1-1), by an AHA postdoctoral fellowship award (AHA 0826071D) and by the “Margarete von Wrangell Habilitation Program” by the MWK Baden Wuerttemberg and the European Social Fund. G. Koren is the recipient of NIH grants 5RO1 HL093205-04 and HL110791-01.

List of Abbreviations

APD

action potential duration

EAD

early afterdepolarization

EST

estradiol

DHT

dihydrotestosterone

ICa,L

L-type Ca2+ current

IK1

inward rectifier K+ current

IKr

rapidly delayed rectifier K+ current

IKs

slow delayed rectifier K+ current

KCNE1

beta-subunit to KvLQT1 to form IKs

KCNE2

beta-subunit to HERG to form IKs

LQTS

long-QT syndrome

LV

left ventricle

NCX

sodium calcium exchanger

ORCH

orchiectomy

OVX

ovariectomy

PLN

phospholamban

PROG

progesterone

pVT

polymorphic ventricular tachycardia

RV

right ventricle

RyR

ryanodine receptor

SCD

sudden cardiac death

SERCA

sarcoplasmatic reticulum ATPase

QT/RR

QT-interval to RR-interval ratio steepness

Footnotes

Conflict of Interest: none

References

  • 1.Wolbrette DL. Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues. Am J Cardiol. 2003;91:39D–44D. doi: 10.1016/s0002-9149(02)03378-7. [DOI] [PubMed] [Google Scholar]
  • 2.Sauer AJ, Moss AJ, McNitt S, et al. Long QT Syndrome in Adults. JACC. 2007;49:329–337. doi: 10.1016/j.jacc.2006.08.057. [DOI] [PubMed] [Google Scholar]
  • 3.Rodriguez I, Kilborn MJ, Liu XK, Pezzullo JC, Woosley RL. Drug-induced QT prolongation in women during the menstrual cycle. JAMA. 2001;285:1322–1326. doi: 10.1001/jama.285.10.1322. [DOI] [PubMed] [Google Scholar]
  • 4.Seth R, Moss AJ, McNitt S, et al. Long QT syndrome and pregnancy. J Am Coll Cardiol. 2007;49:1092–1098. doi: 10.1016/j.jacc.2006.09.054. [DOI] [PubMed] [Google Scholar]
  • 5.Liu XK, Katchman A, Drici MD, Ebert SN, Ducic I, Morad M, Woosley RL. Gender difference in the cycle length-dependent QT and potassium currents in rabbits. J Pharmacol Exp Ther. 1998;285:672–679. [PubMed] [Google Scholar]
  • 6.Vlkovicová J, Javorková V, Pechánová O, Vrbjar N. Gender difference in functional properties of Na, K-ATPase in the heart of spontaneously hypertensive rats. Life Sci. 2005;76(9):971–982. doi: 10.1016/j.lfs.2004.10.013. [DOI] [PubMed] [Google Scholar]
  • 7.Gaborit N, Varro A, Le Boutier S, Szuts V, Escande D, Nattel S, Demolombe S. Gender-related differences in ion-channel and transporter subunit expression in non-diseased human hearts. J Mol Cell Cardiol. 2010;49:639–646. doi: 10.1016/j.yjmcc.2010.06.005. [DOI] [PubMed] [Google Scholar]
  • 8.Furukawa T, Kurokawa J. Non-genomic regulation of cardiac ion channels by sex hormones. Cardiovasc Hematol Disord Drug Targets. 2008;8:245–251. doi: 10.2174/187152908786786160. [DOI] [PubMed] [Google Scholar]
  • 9.Kurokawa J, Tamagawa M, Harada N, Honda S, Bai CX, Nakaya H, Furukawa T. Acute effects of oestradiol on the guinea pig and human IKr channels and drug-induced prolongation of cardiac repolarization. J Physiol. 2008;586:2961–2973. doi: 10.1113/jphysiol.2007.150367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Er F, Michels G, Brandt MC, Khan I, Haase H, Eicks M, Lindner M, Hoppe UC. Impact of testosterone on cardiac L-type calcium channels and Ca2+ sparks: acute actions antagonize chronic effects. Cell Calcium. 2007;41:467–477. doi: 10.1016/j.ceca.2006.09.003. [DOI] [PubMed] [Google Scholar]
  • 11.Nerbonne JM. Molecular basis of functiona voltage-gated K+-channel diversity in the mammalian myocardium. J Physiol. 2000;525:285–298. doi: 10.1111/j.1469-7793.2000.t01-1-00285.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Liu XK, Wang W, Ebert SN, Franz MR, Katchman A, Woosley RL. Female gender is a risk factor for torsades de pointes in an in vitro animal model. J Cardiovasc Pharmacol. 1999;34:287–294. doi: 10.1097/00005344-199908000-00015. [DOI] [PubMed] [Google Scholar]
  • 13.Ando F, Kuruma A, Kawano S. Synergic effects of β-estradiol and erythromycin on hERG currents. J Membr Biol. 2011;241:31–38. doi: 10.1007/s00232-011-9360-z. [DOI] [PubMed] [Google Scholar]
  • 14.Kundu P, Ciobotaru A, Foroughi S, Toro L, Stefani E, Eghbali M. Hormonal regulation of cardiac KCNE2 gene expression. Mol Cell Endocrinol. 2008;292:50–62. doi: 10.1016/j.mce.2008.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Liu XK, Katchman A, Whitfield BH, Wan G, Janowski EM, Woosley RL, Ebert SN. In vivo androgen treatment shortens the QT interval and increases the densities of inward and delayed rectifier potassium currents in orchiectomized male rabbits. Cardiovasc Res. 2003;57:28–36. doi: 10.1016/s0008-6363(02)00673-9. [DOI] [PubMed] [Google Scholar]
  • 16.Drici MD, Burklow TR, Haridasse V, Glazer RI, Woosley RL. Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation. 1996;94:1471–1474. doi: 10.1161/01.cir.94.6.1471. [DOI] [PubMed] [Google Scholar]
  • 17.Palacios J, Marusic ET, Lopez NC, Gonzalez M, Michea L. Estradiol-induced expression of Na-K-ATPase catalytic isoforms in rat arteries: gender differences in activity mediated by nitric oxide donors. Am J Physiol Heart CircPhysiol. 2004;286:H1793–H1800. doi: 10.1152/ajpheart.00990.2003. [DOI] [PubMed] [Google Scholar]
  • 18.January CT, Riddle JM. Early afterdepolarizations: mechanism of induction and block. A role for L-type Ca2+ current. Circ Res. 1989;64:977–990. doi: 10.1161/01.res.64.5.977. [DOI] [PubMed] [Google Scholar]
  • 19.Wasserstrom JA, Kapur S, Jones S, Faruque T, Sharma R, Kelly JE, Pappas A, Ho W, Kadish AH, Aistrup GL. Characteristics of intracellular Ca2+ cycling in intact rat heart: a comparison of sex differences. Am J Physiol Heart Circ Physiol. 2008;295:H1895–H1904. doi: 10.1152/ajpheart.00469.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Farrell SR, Ross JL, Howlett SE. Sex differences in mechanisms of cardiac excitation-contraction coupling in rat ventricular myocytes. Am J Physiol Heart Circ Physiol. 2010;299:H36–H45. doi: 10.1152/ajpheart.00299.2010. [DOI] [PubMed] [Google Scholar]
  • 21.Duan J, Esberg LB, Dai S, Aberle NS, Lopez FL, Ren J. Comparison of cardiac contractile and intracellular Ca2+ response between estrogen and phytoestrogen alpha-zearalanol in ventricular myocytes. Endocrine. 2004;24:33–38. doi: 10.1385/ENDO:24:1:033. [DOI] [PubMed] [Google Scholar]
  • 22.Curl CL, Delbridge LM, Canny BJ, Wendt IR. Testosterone modulates cardiomyocyte Ca(2+) handling and contractile function. Physiol Res. 2009;58:293–297. doi: 10.33549/physiolres.931460. [DOI] [PubMed] [Google Scholar]
  • 23.Cheng J. Evidences of the gender-related differences in cardiac repolarization and the underlying mechanisms in different animal species and human. Fundam Clin Pharmacol. 2006;20:1–8. doi: 10.1111/j.1472-8206.2005.00384.x. [DOI] [PubMed] [Google Scholar]
  • 24.January CT, Gong Q, Zhou Z. Long QT syndrome: cellular basis and arrhythmia mechanism in LQT2. J Cardiovasc Electrophysiol. 2000;11(12):1413–1438. doi: 10.1046/j.1540-8167.2000.01413.x. [DOI] [PubMed] [Google Scholar]
  • 25.Odening KE, Choi BR, Liu GX, Hartmann K, Ziv O, Chaves L, Schofield L, Centracchio J, Zehender M, Peng X, Brunner M, Koren G. Estradiol Promotes Sudden Cardiac Death in Transgenic Long-QT Type 2 Rabbits while Progesterone is Protective. Heart Rhythm. 2012;9:823–832. doi: 10.1016/j.hrthm.2012.01.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Montano LM, Calixto E, Figueroa A, Flores-Soto E, Carbajal V, Perusquia M. Relaxation of androgens on rat thoracic aorta: testosterone concentration dependent agonist/antagonist L-type Ca2+ channel activity, and 5beta-dihydrotestosterone restricted to L-type Ca2+ channel blockade. Endocrinology. 2008;149(5):2517–2526. doi: 10.1210/en.2007-1288. [DOI] [PubMed] [Google Scholar]
  • 27.Bupha-Intr T, Wattanapermpool J. Regulatory role of ovarian sex hormones in calcium uptake activity of cardiac sarcoplasmic reticulum. Am J Physiol Heart Circ Physiol. 2006;291:H1101–H1108. doi: 10.1152/ajpheart.00660.2005. [DOI] [PubMed] [Google Scholar]
  • 28.Tsang S, Wong SS, Wu S, Kravtsov GM, Wong TM. Testosterone-augmented contractile responses to alpha1- and beta1-adrenoceptor stimulation are associated with increased activities of RyR, SERCA, and NCX in the heart. Am J Physiol Cell Physiol. 2009;296:C766–C782. doi: 10.1152/ajpcell.00193.2008. [DOI] [PubMed] [Google Scholar]
  • 29.Filice E, Angelone T, De Francesco EM, Pellegrino D, Maggiolini M, Cerra MC. Crucial role of phospholamban phosphorylation and S-nitrosylation in the negative lusitropism induced by 17β-estradiol in the male rat heart. Cell Physiol Biochem. 2011;28(1):41–52. doi: 10.1159/000331712. [DOI] [PubMed] [Google Scholar]
  • 30.Chu SH, Goldspink P, Kowalski J, Beck J, Schwertz DW. Effect of estrogen on calcium-handling proteins, beta-adrenergic receptors, and function in rat heart. Life Sci. 2006;79:1257–1267. doi: 10.1016/j.lfs.2006.03.037. [DOI] [PubMed] [Google Scholar]
  • 31.Liu CG, Xu KQ, Xu X, Huang JJ, Xiao JC, Zhang JP, Song HP. 17Beta-oestradiol regulates the expression of Na+/K+-ATPase beta1-subunit, sarcoplasmic reticulum Ca2+-ATPase and carbonic anhydrase iv in H9C2 cells. Clin Exp Pharmacol Physiol. 2007;34:998–1004. doi: 10.1111/j.1440-1681.2007.04675.x. [DOI] [PubMed] [Google Scholar]
  • 32.Chen G, Yang X, Alber S, Shusterman V, Salama G. Regional genomic regulation of cardiac sodium-calcium exchanger by oestrogen. J Physiol. 2011;589:1061–1080. doi: 10.1113/jphysiol.2010.203398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Kravtsov GM, Kam KW, Liu J, Wu S, Wong TM. Altered Ca(2+) handling by ryanodine receptor and Na(+)-Ca(2+) exchange in the heart from ovariectomized rats: role of protein kinase A. Am J Physiol Cell Physiol. 2007;292(5):C1625–C1635. doi: 10.1152/ajpcell.00368.2006. [DOI] [PubMed] [Google Scholar]
  • 34.Yan S, Chen Y, Dong M, Song W, Belcher SM, Wang HS. Bisphenol A and 17b-Estradiol Promote Arrhythmia in the Female Heart via Alteration of Calcium Handling. PLoS One. 2011;6(9):e25455. doi: 10.1371/journal.pone.0025455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Walker ML, Rosenbaum DS. Repolarization alternans: implications for the mechanism and prevention of sudden cardiac death. Cardiovascular Research. 2003;57:599–614. doi: 10.1016/s0008-6363(02)00737-x. [DOI] [PubMed] [Google Scholar]
  • 36.Austin C, Chess-Williams R. The influence of 17-beta-oestradiol and the natural oestrous cycle on alpha-adrenoceptor-mediated responses of the cardiovascular system in the rat. J Pharm Pharmacol. 1995;47:656–660. doi: 10.1111/j.2042-7158.1995.tb05854.x. [DOI] [PubMed] [Google Scholar]
  • 37.Liu GX, Choi BR, Ziv O, Li W, de Lange E, Qu Z, Koren G. Differential conditions for early after-depolarizations and triggered activity in cardiomyocytes derived from transgenic LQT1 and LQT2 rabbits. J Physiol. 2012;590:1171–1180. doi: 10.1113/jphysiol.2011.218164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Abi-Gerges N, Small BG, Lawrence CL, Hammond TG, Valentin JP, Pollard CE. Gender differences in the slow delayed (IKs) but not in inward (IK1) rectifier K+ currents of canine Purkinje fibre cardiac action potential: key roles for IKs, beta-adrenoceptor stimulation, pacing rate and gender. Br J Pharmacol. 2006;147:653–660. doi: 10.1038/sj.bjp.0706491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Thawornkaiwong A, Preawnim S, Wattanapermpool J. Upregulation of beta 1-adrenergic receptors in ovariectomized rat hearts. Life Sci. 2003;72:1813–1824. doi: 10.1016/s0024-3205(02)02473-6. [DOI] [PubMed] [Google Scholar]
  • 40.Kam KW, Qi JS, Chen M, Wong TM. Estrogen reduces cardiac injury and expression of beta1-adrenoceptor upon ischemic insult in the rat heart. J Pharmacol Exp Ther. 2004;309:8–15. doi: 10.1124/jpet.103.058339. [DOI] [PubMed] [Google Scholar]
  • 41.Dent MR, Tappia PS, Dhalla NS. Gender related alterations of β-adrenoceptor mechanisms in heart failure due to arteriovenous fistula. J Cell Physiol. 2012;227:3080–3087. doi: 10.1002/jcp.23058. [DOI] [PubMed] [Google Scholar]
  • 42.Antzelevitch C. Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes. Am J Physiol Heart Circ Physiol. 2007;293:H2024–H2038. doi: 10.1152/ajpheart.00355.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Cheng J, Kamiya K, Liu W, Tsuji Y, Toyama J, Kodama I. Heterogeneous distribution of the two components of delayed rectifier K+ current: a potential mechanism of the proarrhythmic effects of methanesulfonanilideclass III agents. Cardiovasc Res. 1999;43:135–147. doi: 10.1016/s0008-6363(99)00061-9. [DOI] [PubMed] [Google Scholar]
  • 44.Pham TV, Rosen MR. Sex hormones, and repolarization. Cardiovasc Res. 2002;53:740–751. doi: 10.1016/s0008-6363(01)00429-1. Review. [DOI] [PubMed] [Google Scholar]
  • 45.Sims C, Reisenweber S, Viswanathan PC, Choi BR, Walker WH, Salama G. Sex, age, and regional differences in L-type calcium current are important determinants of arrhythmia phenotype in rabbit hearts with drug-induced long QT type 2. Circ Res. 2008;102(9):e86–e100. doi: 10.1161/CIRCRESAHA.108.173740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Yang X, Chen G, Papp R, Defranco DB, Zeng F, Salama G. Estrogen upregulates L-type Ca2+ channel via Estrogen-Receptor-α by a regional genomic mechanism in female rabbit hearts. J Physiol. 2012;590:493–508. doi: 10.1113/jphysiol.2011.219501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Takei M, Sasaki Y, Yonezawa T, Lakhe M, Aruga M, Kiyosawa K. The autonomic control of the transmural dispersion of ventricular repolarization in anesthetized dogs. J Cardiovasc Electrophysiol. 1999;10:981–989. doi: 10.1111/j.1540-8167.1999.tb01269.x. [DOI] [PubMed] [Google Scholar]
  • 48.Odening KE, Hyder O, Chaves L, Schofield L, Brunner M, Kirk M, Zehender M, Peng X, Koren G. Pharmacogenomics of anesthetic drugs in transgenic LQT1 and LQT2 rabbits reveal genotype-specific differential effects on cardiac repolarization. Am J Physiol Heart Circ Physiol. 2008;295:H2264–H2272. doi: 10.1152/ajpheart.00680.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Brunner M, Peng X, Liu GX, et al. Mechanisms of cardiac arrhythmias and sudden death in transgenic rabbits with long QT syndrome. J Clin Invest. 2008;118:2246–2259. doi: 10.1172/JCI33578. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Liu T, Choi BR, Drici MD, Salama G. Sex modulates the arrhythmogenic substrate in prepubertal rabbit hearts with Long QT 2. J Cardiovasc Electrophysiol. 2005;16:516–524. doi: 10.1046/j.1540-8167.2005.40622.x. [DOI] [PubMed] [Google Scholar]
  • 51.Cheng J, Su D, Ma X, Li H. Concurrent Supplement of Estradiol and Progesterone Reduces the Cardiac Sensitivity to D,L-Sotalol-Induced Arrhythmias in Ovariectomized Rabbits. J Cardiovasc Pharmacol Ther. 2012;17:208–214. doi: 10.1177/1074248411418972. [DOI] [PubMed] [Google Scholar]
  • 52.Conrath CE, Wilde AA, Jongbloed RJ, Alders M, van Langen IM, van Tintelen JP, Doevendans PA, Opthof T. Gender differences in the long QT syndrome: effects of beta-adrenoceptor blockade. Cardiovasc Res. 2002;53:770–776. doi: 10.1016/s0008-6363(01)00477-1. [DOI] [PubMed] [Google Scholar]
  • 53.Migdalovich D, Moss AJ, Lopes CM, et al. Mutation and gender-specific risk in type 2 long QT syndrome: implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome. Heart Rhythm. 2011;8:1537–1543. doi: 10.1016/j.hrthm.2011.03.049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Buber J, Mathew J, Moss AJ, et al. Risk of recurrent cardiac events after onset of menopause in women with congenital long-QT syndrome types 1 and 2. Circulation. 2011;123:2784–2791. doi: 10.1161/CIRCULATIONAHA.110.000620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Locati EH, Zareba W, Moss AJ, et al. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation. 1998;97:2237–2244. doi: 10.1161/01.cir.97.22.2237. [DOI] [PubMed] [Google Scholar]
  • 56.Somberg JC, Preston RA, Ranade V, Cvetanovic I, Molnar J. Gender Differences in Cardiac Repolarization Following Intravenous Sotalol Administration. J Cardiovascular Pharmacol Ther. 2012;17:86–97. doi: 10.1177/1074248411406505. [DOI] [PubMed] [Google Scholar]
  • 57.Glatz SM, Sorge J, Franke G, Bodi I, Perez-Feliz S, Koren G, Zehender M, Brunner M, Bode C, Odening KE. Scientific Sessions of the American Heart Association. Dallas, TX, USA: 2013. Nov, Postpartum Hormones Oxytocin and Prolactin Alter Cardiac Repolarization in Transgenic Long-QT Type 2 Rabbits by Affecting IKs Current Densities and Ca2+ Cycling Protein Transcription. Abstract. [Google Scholar]
  • 58.Narayanan K, Havmoeller R, Reinier K, Jerger K, Teodorescu C, Uy-Evanado A, Navarro J, Gunson K, Jui J, Chugh SS. Scientific Sessions of the Heart Rhythm Society. Denver, CO, USA: 2013. May, Sex hormone levels and risk of sudden cardiac death. [Google Scholar]

RESOURCES